Jan 31, 2022
Janssen v Apotex
Featuring: Megan Pocalyuko, Juliette Sakran, Peter Wilcox and Marian Wolanski
We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Apotex in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used to treat schizophrenia. This decision represents a significant advance in the application of the law relating to induced infringement.